Related references
Note: Only part of the references are listed.Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Kalliopi Pafili et al.
MOLECULAR METABOLISM (2021)
Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population
Chung-Hao Li et al.
JOURNAL OF DIABETES INVESTIGATION (2020)
Acute and Chronic Effects of Exercise on Continuous Glucose Monitoring Outcomes in Type 2 Diabetes: A Meta-Analysis
Matthew Munan et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study
Pawel Malecki et al.
EXPERT REVIEW OF PROTEOMICS (2020)
Urinary afamin levels are associated with the progression of diabetic nephropathy
Yasushi Kaburagi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease
Lili Niu et al.
MOLECULAR SYSTEMS BIOLOGY (2019)
First-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus
Tina Ravnsborg et al.
PLOS ONE (2019)
Afamin predicts gestational diabetes in polycystic ovary syndrome patients preconceptionally
Angela Koeninger et al.
ENDOCRINE CONNECTIONS (2019)
First trimester serum afamin concentrations are associated with the development of pre-eclampsia and gestational diabetes mellitus in pregnant women
Allessandra Tramontana et al.
CLINICA CHIMICA ACTA (2018)
Combination of first trimester serum afamin levels and three-dimensional placental bed vascularization as a possible screening method to detect women at-risk for adverse pregnancy complications like pre-eclampsia and gestational diabetes mellitus in low-risk pregnancies
Allessandra Tramontana et al.
PLACENTA (2018)
Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study
Angela Koeninger et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2018)
Afamin and adropin in patients with alcohol-induced liver cirrhosis
Andrzej Prystupa et al.
ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE (2018)
Afamin: an early predictor of preeclampsia
Angela Koeninger et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2018)
Upper and Lower Body Muscle Power Increases After 3-Month Resistance Training in Overweight and Obese Men
Erika Zemkova et al.
AMERICAN JOURNAL OF MENS HEALTH (2017)
Plasma Concentrations of Afamin Are Associated With Prevalent and Incident Type 2 Diabetes: A Pooled Analysis in More Than 20,000 Individuals
Barbara Kollerits et al.
DIABETES CARE (2017)
Plasma Concentrations of Afamin Are Associated With the Prevalence and Development of Metabolic Syndrome
Florian Kronenberg et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2014)
The serum proteome of nonalcoholic fatty liver disease: A multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis
Michael H. Miller et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies
Timea Kurdiova et al.
JOURNAL OF PHYSIOLOGY-LONDON (2014)
Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
Beata Seeber et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2014)
Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome
Angela Koeninger et al.
ENDOCRINE CONNECTIONS (2014)
Proteomic analysis of retinopathy-related plasma biomarkers in diabetic patients
Chieh-Hsiang Lu et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2013)
Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma
Benjamin Dieplinger et al.
CLINICA CHIMICA ACTA (2013)
Afamin secreted from nonresorbing osteoclasts acts as a chemokine for preosteoblasts via the Akt-signaling pathway
Beam-Jun Kim et al.
BONE (2012)
The Mouse Alpha-Albumin (Afamin) Promoter Is Differentially Regulated by Hepatocyte Nuclear Factor 1α and Hepatocyte Nuclear Factor 1β
Hua Liu et al.
DNA AND CELL BIOLOGY (2011)
Exercise and fat accumulation in the human liver
Faidon Magkos
CURRENT OPINION IN LIPIDOLOGY (2010)
Afamin is synthesized by cerebrovascular endothelial cells and mediates α-tocopherol transport across an in vitro model of the blood-brain barrier
Ingrid Kratzer et al.
JOURNAL OF NEUROCHEMISTRY (2009)
How to measure hepatic insulin resistance?
S. -P. Choukem et al.
DIABETES & METABOLISM (2008)
Impaired fasting glucose and impaired glucose tolerance - Implications for care
David M. Nathan et al.
DIABETES CARE (2007)
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
Giorgio Bedogni et al.
BMC GASTROENTEROLOGY (2006)
Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance - Results from the veterans administration genetic epidemiology study
MA Abdul-Ghani et al.
DIABETES (2006)
Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression
L Jerkovic et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Characterization of the vitamin E-binding properties of human plasma afamin
AF Voegele et al.
BIOCHEMISTRY (2002)
Significant down-regulation of alpha-albumin in human hepatoma and its implication
GX Wu et al.
CANCER LETTERS (2000)
Share Paper
